PBI
Pressure BioSciences
美PBI Pressure BioSciences, Inc. www.pressurebiosciences.com
Pressure BioSciences, Inc. (PBI)美國高壓生物科學公司（NASDAQ:PBIO），是世界上最專業的高壓樣品處理系統研發和生產廠商。該公司的總部在波士頓，其核心技術人員為麻省理工學院，哈佛大學，和耶魯大學工作過的博士們。其研制生產的壓力循環樣品處理系統PCT SPS）,為生物樣品前處理提供了前所未有的革命性技術。
PCT高壓循環技術Pressure Cycling Technology 是一項全新、高效的生物樣品制備專利。它利用多次的常壓和超高（液）壓（35,000 PSI或更高)之間壓力快速循環，實現生物分子精準提取。可以徹底改變過去、現在和未來生物領域的各種麻煩的樣品前處理，徹底改變傳統的思路。廣泛的應用于法醫鑒定樣品處理，基因組學和蛋白質組學研究樣品處理，藥物研發，環境科學等。
We are a life sciences company focused on the development and commercialization of a novel, enabling, platform technology called pressure cycling technology ("PCT"). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions.
Our pressure cycling technology uses internally developed instrumentation that is capable of cycling pressure between ambient and ultra-high levels at controlled temperatures to rapidly and repeatedly control the interactions of bio-molecules. Our instrument, the Barocycler®, and our internally developed consumables product line, which includes PULSE (Pressure Used to Lyse Samples for Extraction) Tubes as well as the ProteoSolveLRS™ kit for the detergent-free extraction of proteins from lipid-rich samples, together make up the PCT Sample Preparation System ("PCT SPS").
Our pressure cycling technology employs a unique approach that we believe has the potential for broad applications in a number of established and emerging life sciences areas, including;
Sample preparation for genomic, proteomic, and small molecule studies;
Pathogen inactivation;
Protein purification;
Control of chemical (enzymatic) reactions; and
Immunodiagnostics
Since we began operations as Pressure BioSciences in February 2005, we have focused substantially all of our research and development and commercialization efforts on sample preparation for genomic, proteomic, and small molecule studies.
Our business strategy is to commercialize pressure cycling technology in the area of sample preparation for genomic, proteomic, and small molecule studies ("sample preparation"). We also plan to pursue the further development and commercialization of PCT in other life sciences applications, which could include working with various strategic partners that have greater scientific, and regulatory, expertise in the respective applications than we do.
